Evidence map›Paper›PMID 40120690›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2025

Intracellular delivery of proteins for live cell imaging.

Ban-Seok Jeong, Hwanhee C Kim, Catherine M Sniezek, Stephanie Berger, Justin M Kollman, David Baker, Joshua C Vaughan, Xiaohu Gao

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ban-Seok JeongDepartment of Bioengineering, University of Washington, United States of America.
Hwanhee C KimDepartment of Chemistry, University of Washington, United States of America.
Catherine M SniezekInstitute for Protein Design, University of Washington, United States of America.
Stephanie BergerInstitute for Protein Design, University of Washington, United States of America.
Justin M KollmanDepartment of Biochemistry, University of Washington, United States of America. Electronic address: jkoll@uw.edu.
David BakerInstitute for Protein Design, University of Washington, United States of America; Department of Biochemistry, University of Washington, United States of America; Howard Hughes Medical Institute, University of Washington, United States of America. Electronic address: dabaker@uw.edu.
Joshua C VaughanDepartment of Chemistry, University of Washington, United States of America; Department of Neurobiology and Biophysics, University of Washington, United States of America. Electronic address: jcv2@uw.edu.
Xiaohu GaoDepartment of Bioengineering, University of Washington, United States of America. Electronic address: xgao@uw.edu.

Funding

Live-cell intracellular immunofluorescenceR21CA263698 · NCI · UNIVERSITY OF WASHINGTON · PI GAO, XIAOHU · 2021 to 2022
$395k
Howard Hughes Medical InstituteNCI NIH HHS R21 CA263698
6 · The paper itself

Abstract

The majority of cellular functions are regulated by intracellular proteins, and regulating their interactions can unlock fundamental insights in biology and open new avenues for drug discovery. Because the vast majority of intracellular targets remain undruggable, there is significant current interest in developing protein-based agents especially monoclonal antibodies due to their specificity, availability, and established screening/engineering methods. However, efficient delivery of proteins into the cytoplasm has been a major challenge in biological engineering and drug discovery. We previously reported a platform technology based on a Coomassie blue-cholesterol conjugate (CB-tag) capable of delivering small proteins directly into the cytoplasm. Here, we report a new generation of CB-tag that can bring proteins with a wide size range into the cytoplasm, bypassing endosomal sequestration. Remarkably, intracellular targets with distinct structures were visualized. Overall, the new CB-tag demonstrated a robust ability in protein delivery with broad applications ranging from live-cell immunofluorescence to protein-based therapeutic development.

Indexed as

CholesterolCytoplasmDrug Delivery SystemsProteinsAnimalsHeLa CellsHumansCholesterolProteinsAntibodyCytosolic deliveryDrug discoveryLive-cell imagingProteinSmall molecule

Identifiers

PMID40120690
PMCPMC13671267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.